Ultra-Purified Microbial Fractions: A New Frontier in FMT-Derived Therapeutics
9:00 am - Thursday 29th January 2026
- Showcase a proprietary manufacturing process that isolates microbial fractions while discarding faecal material
- Present preclinical data in infectious disease, melanoma, and colorectal cancer models
- Prepare for IND submission and clinical trial initiation to validate cross-indication potential
